Please Wait.....
Report
Transcatheter Pulmonary Valve - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 130 Pages I Mordor Intelligence
Transcatheter Pulmonary Valve Market Analysis
The global transcatheter pulmonary valve market is valued at USD 77.76 million in 2025 and is projected to reach USD 101.87 million by 2030, expanding at a 5.55% CAGR over the forecast horizon. An expanding cohort of adult survivors of congenital heart disease (CHD), rapid device approvals, and supportive reimbursement updates are sustaining demand. Self-expanding platforms are doubling the addressable patient pool by treating large native right ventricular outflow tracts (RVOT), while balloon-expandable valves remain indispensable for conduit-based anatomies. Payer policies increasingly reward outpatient cath-lab procedures, accelerating the shift from tertiary surgical centers to ambulatory facilities. Regulatory vigilance around durability and endocarditis continues to temper near-term adoption but also drives sustained R&D investment in advanced tissue processing and anti-calcification technologies.
Global Transcatheter Pulmonary Valve Market Trends and Insights
Rising Adult-Survivor CHD Population
Adults living with congenital heart defects now exceed 1 million in the United States, 20% of whom require complex cardiac re-interventions. Hospitalizations are 91% higher and average USD 81,332 per stay versus USD 49,000 for non-congenital heart failure, incentivizing payers to endorse less invasive options. Strong long-term tissue durability-99.3% freedom from structural deterioration over eight years-supports device longevity expectations. The demographic trajectory ensures persistent case flow across developed markets.
Rapid Approvals of Self-Expanding TPV Platforms
Multicenter registry data covering 243 U.S. patients recorded 98% acceptable hemodynamics and 99% freedom from major composite events at one-year follow-up. UK regulators granted exceptional approval for the Venus P-valve despite a pending CE mark, signaling readiness to fast-track solutions addressing unmet needs. Ability to land securely in large native RVOT anatomies effectively doubles the clinical universe.
Durability and Strict Post-Market Surveillance
FDA registries logged 631 adverse events for Melody implants, including stent fragment embolization. Ten-year freedom from dysfunction sits at 53% in pediatric cohorts, driving regulatory calls for harmonized durability definitions. Although RESILIA tissue shows encouraging eight-year durability, pulmonary positioning evidence remains early stage.
Other drivers and restraints analyzed in the detailed report include:
Patient and Clinician Shift to Minimally Invasive Therapies / Investment Surge from Leading Med-Tech Strategics / Endocarditis Uptick Triggering Caution in Key Centers /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Global revenue remains anchored by balloon-expandable devices, which commanded 58.35% of the transcatheter pulmonary valve market share in 2024. Precise conduit sizing, immediate anchoring, and robust long-term data sustain clinician confidence. The Edwards SAPIEN 3 system achieved 98.1% device success and 100% freedom from surgical reintervention at one year. At the same time, self-expanding solutions are advancing at 12.25% CAGR through 2030, transforming therapeutic possibilities for enlarged native RVOT anatomies. One-year registry follow-up showed 96% freedom from composite events with acceptable hemodynamics in 98% of cases. The Venus P-valve and Harmony systems now anchor treatment algorithms in Asia and North America respectively, with CE certification further broadening access.
Pulmonary regurgitation generated 45.53% of 2024 procedure volume, reflecting historical focus on volume-overload correction. Nonetheless, pulmonary stenosis indications are forecast to post a 10.85% CAGR, the strongest trajectory within the transcatheter pulmonary valve market. Earlier intervention strategies that aim to pre-empt right-ventricular compromise underpin this acceleration, especially for repaired Tetralogy of Fallot patients. Comparative trials such as COMPASS will clarify optimal timing and modality selection, potentially increasing stenosis-related volumes.
The Transcatheter Pulmonary Valve Market Report is Segmented by Technology (Balloon-Expanded Valve and Self-Expanded Valve), Application (Pulmonary Stenosis, Pulmonary Regurgitation, and More), End-User (Pediatric Hospitals, Pulmonary Regurgitation, and More), RVOT Anatomy (Conduit-Based RVOT and Native / Enlarged RVOT), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America generated 38.82% of global revenue in 2024, buoyed by advanced centers, widespread payer support, and active clinical-trial pipelines. CMS's 2.9% outpatient payment hike and new device categories accelerate catheter-lab uptake. Canada and Mexico are scaling specialist capabilities, supported by cross-border training and regional clinical studies.
Europe sustains mid-single-digit growth, underpinned by mature infrastructure and adaptable regulators willing to expedite devices with demonstrable need. Exceptional UK approval of Venus P-valve underscores demand-driven flexibility. Health-economic studies from Spain showed favorable EUR 6,952 per QALY, reinforcing payer confidence.
Asia-Pacific represents the fastest regional expansion at 10.61% CAGR. Domestic innovators such as Venus Medtech tailor self-expanding valves for prevalent anatomical features in Chinese and Indian populations. Japan's registry exceeding 8,000 transcatheter aortic cases provides a procedural blueprint for pulmonary adoption. Government initiatives to expand cardiac catheterization labs in South Korea and Australia further catalyze uptake.
South America and the Middle East & Africa trail but show rising interest as referral pathways mature. Partnerships with global device makers and training exchanges with European centers are improving procedural readiness. Incremental gains in reimbursement coverage, especially for pediatric CHD, are expected to translate into a steady but smaller share of the transcatheter pulmonary valve market by 2030.
List of Companies Covered in this Report:
Medtronic / Edward Lifesciences / Boston Scientific / Abbott Laboratories / Venus MedTech (Hangzhou) Inc. / Artivion, Inc. / Jenavalve Technology / LivaNova / Braile Biomedica / PolyVascular Inc. / Xeltis AG / MicroPort CardioFlow Medtech Corp. / Terumo / Meril Life Sciences Pvt Ltd (MyVal) / T&N Medical (Pulsta Valve) / Lepu Medical / BIOTRONIK / Peijia Medical Ltd. / OrbusNeich Medical Group /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Adult-Survivor CHD Population
4.2.2 Rapid Approvals Of Self-Expanding TPV Platforms
4.2.3 Patient & Clinician Shift To Minimally-Invasive Therapies
4.2.4 Investment Surge From Leading Med-Tech Strategics
4.2.5 Expansion Of Outpatient Cath-Lab Reimbursement Codes
4.3 Market Restraints
4.3.1 Durability & Strict Post-Market Surveillance
4.3.2 Surgical Alternatives (Ross, Homografts) Remain Viable
4.3.3 Endocarditis Uptick Triggering Caution In Key Centers
4.4 Porter's Five Forces
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitutes
4.4.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Technology
5.1.1 Balloon-Expandable Valve
5.1.2 Self-Expanding Valve
5.2 By Application
5.2.1 Pulmonary Stenosis
5.2.2 Pulmonary Regurgitation
5.2.3 Tetralogy-of-Fallot Post-Repair
5.2.4 Others
5.3 By End-User
5.3.1 Pediatric Hospitals
5.3.2 Adult Congenital Heart Centers
5.3.3 Ambulatory Surgical Centers
5.4 By RVOT Anatomy
5.4.1 Conduit-Based RVOT
5.4.2 Native / Enlarged RVOT
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 Rest of the World
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Medtronic PLC
6.3.2 Edwards Lifesciences Corporation
6.3.3 Boston Scientific Corporation
6.3.4 Abbott Laboratories
6.3.5 Venus MedTech (Hangzhou) Inc.
6.3.6 Artivion, Inc.
6.3.7 JenaValve Technology, Inc.
6.3.8 LivaNova PLC
6.3.9 Braile Biomedica
6.3.10 PolyVascular Inc.
6.3.11 Xeltis AG
6.3.12 MicroPort CardioFlow Medtech Corp.
6.3.13 Terumo Corporation
6.3.14 Meril Life Sciences Pvt Ltd (MyVal)
6.3.15 T&N Medical (Pulsta Valve)
6.3.16 Lepu Medical Technology Co., Ltd.
6.3.17 Biotronik SE & Co. KG
6.3.18 Peijia Medical Ltd.
6.3.19 OrbusNeich Medical Group
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security